Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,214	3,656	3,716	6,465	6,688	6,925
Market Cap Growth	-1.61%	-1.61%	-42.53%	-3.33%	-3.43%	-
Enterprise Value	3,000	3,442	3,055	5,391	5,318	6,738
Last Close Price	8.58	9.76	9.92	17.26	18.59	19.25
PS Ratio	24.82	28.24	32.52	76.29	165.12	148.54
PB Ratio	2.80	3.18	2.77	3.87	3.65	3.24
P/TBV Ratio	3.30	3.75	3.34	4.57	4.26	3.74
EV/Sales Ratio	23.17	26.59	26.74	63.61	131.30	144.52
Debt / Equity Ratio	0.39	0.39	0.28	0.17	0.16	0.02
Asset Turnover	-	-	0.05	0.03	0.02	0.03
Inventory Turnover	-	-	1.42	1.47	1.91	2.58
Quick Ratio	-	-	2.65	4.64	3.76	16.07
Current Ratio	-	-	2.90	5.07	3.95	16.40
Return on Equity (ROE)	-16.17%	-16.17%	-21.83%	-20.38%	-13.36%	-17.17%
Return on Assets (ROA)	-	-	-9.45%	-10.08%	-7.95%	-8.88%
Return on Capital (ROIC)	-7.57%	-7.57%	-11.71%	-12.23%	-9.35%	-10.90%
Earnings Yield	-6.27%	-5.51%	-8.85%	-5.52%	-3.89%	-3.33%
FCF Yield	-	-	-10.67%	-6.64%	-8.53%	-5.15%
Buyback Yield / Dilution	0.17%	0.17%	-2.69%	-0.79%	-25.23%	-9.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.